{"doc_id": "si-2023-0105-reg-3", "parent_doc_id": "si-2023-0105", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 105 of 2023", "title": "“Regulations of 2023” means the Medicinal Products (Prescription and Control", "year": 2023, "heading": "3. The Twelfth Schedule (as amended by Regulation 4 of the Regulations", "text_raw": "3. The Twelfth Schedule (as amended by Regulation 4 of the Regulations \n\nof 2023) to the Principal Regulations is amended— \n\n(a) \n\nin the entry for “Comirnaty Original/Omicron BA.4-5 (15/15 \nmicrograms)/dose dispersion for injection COVID-19 mRNA \nVaccine (nucleoside modified)”— \n\n(i) \n\nin column 4, by deleting “and who have previously \nreceived at least a primary vaccination course against \nCOVID-19”, and \n\n(ii) \n\nin column 5— \n\n(I) \n\nby deleting “and have previously received at least a \nprimary vaccination course against COVID-19”, and \n\n(II) by deleting “with an interval of not less than 4 \nmonths, or 3 months in exceptional circumstances, \nbetween administration of the product and the last \nprior dose of a COVID-19 vaccine, or confirmed \nSARS-CoV-2 infection”, and \n\n(b) \n\nin the entry for “Comirnaty Original/Omicron BA.4-5 (5/5 \nmicrograms)/dose concentrate for injection COVID-19 mRNA \nVaccine (nucleoside modified)”— \n\n(i) \n\nin column 4, by deleting “who have previously received at \nleast a primary vaccination course against COVID-19”, \nand \n\n(ii) \n\nin column 5, by deleting “and have previously received at \nleast a primary vaccination course against COVID-19”. \n\nGIVEN under my Official Seal, \n\n7 March, 2023. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f4 [105]", "text_norm": "3 twelfth schedule (as amended regulation 4 regulation 2023) principal regulation amended-- (a) entry comirnaty original omicron ba.4-5 (15 15 micrograms) dose dispersion injection covid-19 mrna vaccine (nucleoside modified) -- (i) column 4 deleting previously received least primary vaccination course covid-19 (ii) column 5-- (i) deleting previously received least primary vaccination course covid-19 (ii) deleting interval le 4 month 3 month exceptional circumstance administration product last prior dose covid-19 vaccine confirmed sars-cov-2 infection (b) entry comirnaty original omicron ba.4-5 (5 5 micrograms) dose concentrate injection covid-19 mrna vaccine (nucleoside modified) -- (i) column 4 deleting previously received least primary vaccination course covid-19 (ii) column 5 deleting previously received least primary vaccination course covid-19  given official seal 7 march 2023 stephen donnelly minister health 4 105", "start_char": 2518, "end_char": 3833, "source_path": "downloads\\2023\\2023_0105.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dae1b4d9e85116239d93b2c7211836da813ec4c30346c2f63c40b1667d5783da", "cross_refs": []}
{"doc_id": "si-2023-0105-explanatory-note", "parent_doc_id": "si-2023-0105", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 105 of 2023", "title": "“Regulations of 2023” means the Medicinal Products (Prescription and Control", "year": 2023, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to allow for certain bivalent COVID-19 \nvaccines to be used as the primary vaccination course. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 2) Regulations 2023. \n\n \n \n \n \n \n \n \n\f[105] 5 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-472) 75. 3/23. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation allow certain bivalent covid-19 vaccine used primary vaccination course regulation may cited medicinal product (prescription control supply) (amendment) (no 2) regulation 2023 105 5 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-472) 75 3 23 propylon", "start_char": 3833, "end_char": 4829, "source_path": "downloads\\2023\\2023_0105.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dae1b4d9e85116239d93b2c7211836da813ec4c30346c2f63c40b1667d5783da", "cross_refs": []}
